122
Participants
Start Date
October 31, 2025
Primary Completion Date
June 30, 2028
Study Completion Date
June 30, 2028
Semaglutide 2.4mg
The active comparator of the intervention is s.c. Semaglutide injection once a week in increasing doses every month from 0.25 mg to 0.5 mg to 1.0 mg to 1.7 mg to 2.4 mg and the placebo comparator is s.c. injection with a visually identical and same label pen as described for the active comparator
Semaglutide placebo
Visually identical and same label as the active comparator intervention
Nordsjaellands Hospital, Hillerød
Steno Diabetes Center Copenhagen
OTHER
Steno Diabetes Center Odense
OTHER
Zealand University Hospital
OTHER
Steno Diabetes Center Aarhus (SDCA), Aarhus University Hospital
UNKNOWN
Nordsjaellands Hospital
OTHER